Severe Cutaneous Adverse Reaction (SCAR): Clinical pharmacologists' viewpoint

Severe Cutaneous Adverse Reaction (SCAR): Clinical pharmacologists' viewpoint

Bibliographic Details
Main Authors:	Nusrat Shafiq, Samiksha Bhattacharjee, Samir Malhotra
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2022-01-01
Series:	Indian Dermatology Online Journal
Online Access:	http://www.idoj.in/article.asp?issn=2229-5178;year=2022;volume=13;issue=1;spage=10;epage=12;aulast=Shafiq

Similar Items

Chemokines in Severe Cutaneous Adverse Reactions (SCARs)
by: Fumi Miyagawa, et al.
Published: (2021-06-01)

Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)
by: Andrew Carr, et al.
Published: (2022-08-01)

Why clinical pharmacologists are needed?
by: Andrea Giménez
Published: (2012-06-01)

What do clinical pharmacologists do? A questionnaire survey of senior UK clinical pharmacologists.
by: Aronson, J
Published: (2012)

Tolerated drugs in subjects with severe cutaneous adverse reactions (SCARs) induced by anticonvulsants and review of the literature
by: Fabrizio De Luca, et al.
Published: (2017-10-01)

Polypragmasy: A clinical pharmacologist’s view
by: D A Sychev, et al.
Published: (2016-12-01)

Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR registry
by: Min-Hye Kim, MD, PhD, et al.
Published: (2023-01-01)

Treatments for Severe Cutaneous Adverse Reactions
by: Yung-Tsu Cho, et al.
Published: (2017-01-01)

Genetics of Severe Cutaneous Adverse Reactions
by: Shang-Chen Yang, et al.
Published: (2021-07-01)

Severe Cutaneous Adverse Drug Reaction
by: Damayanti Damayanti, et al.
Published: (2017-08-01)

Analysis of severe cutaneous adverse reactions (SCARs) in Taiwan drug-injury relief system: 18-year results
by: Po-Wei Huang, et al.
Published: (2022-08-01)

Role of pharmacologists in clinical research: The onus is on us
by: Jagjit Singh
Published: (2013-01-01)

An algorithm for the selection of antiarrhythmic drugs for clinical pharmacologist
by: A. A. Upnitskiy
Published: (2014-12-01)

DIPEPTIDYL DIPEPTIDASE-4: VIEW OF THE CLINICAL PHARMACOLOGIST
by: N. B. LAZAREVA
Published: (2016-12-01)

Clinical pharmacogenetics of antiaggregants: clinical pharmacologist' point of view
by: D. A. Syche, et al.
Published: (2007-08-01)

A Flexible Regimen of Combination Antihypertensive Therapy for Lower Blood Pressure to the Lower Target Level. Viewpoint of Cardiologist and Clinical Pharmacologist
by: S. R. Gilyarevskiy, et al.
Published: (2019-05-01)

Pharmacovigilance of Severe Cutaneous Adverse Drug Reactions
by: Kriteeka Saini, et al.
Published: (2022-01-01)

PharmSuitePro - the automated workplace of clinical pharmacologist
by: V. M. Tcvetov
Published: (2020-04-01)

Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions
by: Mari Orime
Published: (2017-01-01)

Recent advances in severe cutaneous adverse drug reaction
by: Sudip Das, et al.
Published: (2018-01-01)

Perspectives on training quantitative systems pharmacologists
by: Tongli Zhang, et al.
Published: (2022-06-01)

David Grahame Grahame-Smith: clinical pharmacologist. 1933-2011.
by: Aronson, J
Published: (2012)

Combined Therapy of Arterial Hypertension. The Opinion of a Clinical Pharmacologist
by: M. V. Zhuravleva, et al.
Published: (2020-09-01)

ANALGETICS-ANTIPYRETICS IN PEDIATRICIAN’S PRACTICE: THE POINT OF VIEW OF CLINICAL PHARMACOLOGIST
by: G.G. Ketova
Published: (2009-11-01)

ANALGETICS-ANTIPYRETICS IN PEDIATRICIAN’S PRACTICE: THE POINT OF VIEW OF CLINICAL PHARMACOLOGIST
by: G.G. Ketova
Published: (2009-01-01)

Beta-blockers in cardiac arrhythmias–Clinical pharmacologist’s point of view
by: Łukasz Wołowiec, et al.
Published: (2023-01-01)

Long-term outcome of patients with severe cutaneous adverse reactions
by: Yoko Kano, et al.
Published: (2013-12-01)

Cytotoxic Proteins and Therapeutic Targets in Severe Cutaneous Adverse Reactions
by: Shih-Chi Su, et al.
Published: (2014-01-01)

Severe cutaneous adverse drug reactions: A clinicoepidemiological study
by: Sarita Sasidharanpillai, et al.
Published: (2015-01-01)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
by: Chih-Jung Chang, et al.
Published: (2020-07-01)

PRACTICAL ASPECTS OF APIXABAN USE IN CLINICAL PRACTICE: VIEW POINT OF CLINICAL PHARMACOLOGIST
by: D. A. Sychev, et al.
Published: (2015-09-01)

PRACTICAL ASPECTS OF APIXABAN USE IN CLINICAL PRACTICE: VIEW POINT OF CLINICAL PHARMACOLOGIST
by: D. A. Sychev, et al.
Published: (2015-09-01)

Sports pharmacology: A medical pharmacologist’s perspective
by: Harshad O Malve
Published: (2018-01-01)

Pharmacologists′ participation in teaching hospitals for shaping future clinical research in India
by: Mohammed Imran
Published: (2012-01-01)

Medication errors in hematology-oncology ward by consultation : the role of the clinical pharmacologist
by: Ali Eishy Oskoyi, et al.
Published: (2021-01-01)

The Contribution of Clinical Pharmacologists in Precision Medicine: An Opportunity for Health Care Improvement
by: Davide Grisafi, PhD, PharmD, et al.
Published: (2021-01-01)

New Aspects of the Antibiotics Use in Ophthalmology: the View of a Clinical Pharmacologist
by: G. Yu. Knorring
Published: (2024-10-01)

Biapenem: Clinical and Microbiological Characteristics and the Place of The New Carbapenem In The Treatment of Severe Infections In The Hospital. Clinical Pharmacologists' Point of View
by: S. V. YAKOVLEV, et al.
Published: (2022-09-01)

Cutaneous Scarring: A Clinical Review
by: Richard Baker, et al.
Published: (2009-01-01)

Adverse cutaneous drug reaction
by: Nayak Surajit, et al.
Published: (2008-01-01)